ARAY
Accuray Incorporated
NASDAQ · Healthcare · Medical - Devices · US
$0.27
+0.30%Aug 19, 2026, 00:00 UTC
Accuray Inc reported Q4 2026 revenue of $100.9 million, down 21% year-over-year, with a net loss of $1.9 million and diluted EPS of -$0.02.
Aug 12, 2026, 21:09 UTC
Accuray Incorporated announced two key executive leadership appointments to improve operational execution and profitability as part of its transformation plan.
Source:Aug 6, 2026, 00:00 UTC
Accuray Inc. received a notice from NASDAQ on August 4, 2026, that it was not in compliance with the exchange's minimum bid price requirement, and has until February 1, 2027, to regain compliance.
Jul 29, 2026, 00:00 UTC
Accuray Inc. signed a private placement of Series A Convertible Preferred Stock and warrants, raising $15 million in cash and converting $40 million of existing debt into equity.